RecruitingNot Applicable

Speech Treatment for Minimally Verbal Children With ASD and CAS

United States20 participantsStarted 2024-05-01

Plain-language summary

Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.

Who can participate

Age range

5 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meets criteria for Autism Spectrum Disorder * Able to correctly repeat at least 2 syllables * Meets criteria for Childhood Apraxia of Speech * Lives in an environment where child is exposed to English at least 50% of the time Exclusion Criteria: * Poorly controlled seizures * Factors such as blindness or deafness that contribute to minimally verbal status * Lives in an environment where English is not spoken at least 50% of the time * Child experiences behavioral challenges that preclude participation in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Attempts Correct

Timeframe: 5 weeks

Phonemes Correct

Timeframe: 5 weeks

Trial details

NCT IDNCT05066178

SponsorMGH Institute of Health Professions

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-04-30

Contact for this trial

Karen V Chenausky, Ph.D.

617-726-2405 kvchenausky@mghihp.edu

View on ClinicalTrials.gov More Developmental Verbal Dyspraxia trials